Proinsulin Shares a Motif with Interleukin-1α (IL-1α) and Induces Inflammatory Cytokine via Interleukin-1 Receptor 1*

Although it has been established that diabetes increases susceptibility to infections, the role of insulin (INS) in the immune response is unknown. Here, we investigated the immunological function of INS. Proinsulin dimer (pINSd) was a potent immune stimulus that induced inflammatory cytokines, but mature INS was unable to induce an immune response. An affinity-purified rabbit polyclonal antibody raised against mature IL-1α recognized IL-1α and pINS but failed to detect mature INS and IL-1β. Analysis of the pINS sequence revealed the existence of an INS/IL-1α motif in the C-peptide of pINS. Surprisingly, the INS/IL-1α motif was recognized by monoclonal antibody raised against IL-1α. Deleting the INS/IL-1α motif in pINSd and IL-1α changed their activities. To investigate the pINSd receptor, the reconstitution of IL-1 receptor 1 (IL-1R1) in Wish cells restored pINSd activity that was reversed by an IL-1R antagonist. These data suggested that pINSd needs IL-1R1 for inflammatory cytokine induction. Mouse embryo fibroblast cells of IL-1R1-deficient mice further confirmed that pINSd promotes immune responses through IL-1R1.

[1]  L. Dimeglio,et al.  Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes. , 2016, Translational research : the journal of laboratory and clinical medicine.

[2]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[3]  G. Bancroft,et al.  Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection , 2013, Scientific Reports.

[4]  C. Dinarello,et al.  The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines , 2013, Front. Immunol..

[5]  C. Dinarello,et al.  Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice , 2013, Gut.

[6]  Darrell M. Wilson,et al.  Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials , 2013, The Lancet.

[7]  Soohyun Kim,et al.  Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant* , 2011, The Journal of Biological Chemistry.

[8]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[9]  S. Malozowski,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[10]  V. Tesar,et al.  [Urinary tract infection in patients with diabetes mellitus]. , 2006, Vnitrni lekarstvi.

[11]  D. Yoon,et al.  Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Knobler,et al.  Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. , 2000, Mayo Clinic proceedings.

[13]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[14]  A. Gasbarrini,et al.  Helicobacter pylori infection in patients affected by insulin‐dependent diabetes mellitus , 1998, European journal of gastroenterology & hepatology.

[15]  J. Myśliwska,et al.  Significance of tumor necrosis factor alpha in patients with long-standing type-I diabetes mellitus. , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[16]  M. Labow,et al.  Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.

[17]  F. Numano,et al.  The Effect of Glucose and Advanced Glycosylation End Products on IL‐6 Production by Human Monocytes , 1994, Annals of the New York Academy of Sciences.

[18]  M. Suthanthiran,et al.  Advanced glycosylation endproduct-specific receptors on human and rat T- lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling , 1993, The Journal of experimental medicine.

[19]  Y. Ohno,et al.  In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.

[20]  B. Keagy,et al.  The course of severe foot infection in patients with diabetes. , 1992, Surgery, gynecology & obstetrics.

[21]  A J Scheen,et al.  Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. , 1992, Diabete & metabolisme.

[22]  P. Scuderi,et al.  Serum Levels of Tumor Necrosis Factor and IL-1α and IL-1β in Diabetic Patients , 1991, Diabetes Care.

[23]  M. T. Brewer,et al.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.

[24]  L. Samaranayake,et al.  Secretor status, candidal carriage and candidal infection in patients with diabetes mellitus. , 1988, Journal of oral pathology.

[25]  C. March,et al.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. , 1988, Science.

[26]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[27]  D. Williams,et al.  Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins. , 1982, Science.

[28]  W. Rutter,et al.  Isolation and characterization of a cloned rat insulin gene , 1979, Cell.

[29]  B. Eiseman,et al.  Depression of cell-mediated immunity in diabetes. , 1978, Archives of surgery.

[30]  J. Casey,et al.  Impaired response of lymphocytes of diabetic subjects to antigen of Staphylococcus aureus. , 1977, The Journal of infectious diseases.

[31]  W. Rutter,et al.  Rat insulin genes: construction of plasmids containing the coding sequences. , 1977, Science.

[32]  A. Kitabchi.  Proinsulin and C-peptide: a review. , 1977, Metabolism: clinical and experimental.

[33]  J. Nerup,et al.  Cell-mediated immunity in diabetes mellitus. , 1974, Proceedings of the Royal Society of Medicine.

[34]  T. Blundell,et al.  Atomic Positions in Rhombohedral 2-Zinc Insulin Crystals , 1971, Nature.

[35]  F. Sanger,et al.  The amino-acid sequence in the phenylalanyl chain of insulin. I. The identification of lower peptides from partial hydrolysates. , 1951, The Biochemical journal.

[36]  W R Campbell,et al.  Further Clinical Experience with Insulin (Pancreatic Extracts) in the Treatment of Diabetes Mellitus , 1923, British medical journal.

[37]  J. Macleod.  INSULIN AND DIABETES , 1922, British medical journal.

[38]  B. Wierusz-Wysocka,et al.  Serum interleukin-8 level is increased in diabetic patients , 1999, Diabetologia.

[39]  W. Rutter,et al.  Rat insulin genes: construction of plasmids containing the coding sequences. 1977. , 1992, Biotechnology.

[40]  P. Pozzilli,et al.  Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus. , 1984, Biomedica biochimica acta.

[41]  H. Polk,et al.  The mechanism of infection in patients with diabetes mellitus: a review of leukocyte malfunction. , 1974, Surgery.